Orion Oyj (OTCMKTS:ORINF) Shares Up 3.2% – Here’s What Happened

Orion Oyj (OTCMKTS:ORINF) shares were up 3.2% during trading on Wednesday . The company traded as high as $48.65 and last traded at $48.65. Approximately 200 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 1,080 shares. The stock had previously closed at $47.16.

Orion Oyj Trading Up 3.2 %

The stock has a 50-day moving average price of $47.16 and a 200 day moving average price of $47.16.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.